IP Library Granted Patent US 10,479,979
Granted Patent B2
US 10,479,979 · App. 15/392,620 · Granted Nov 19, 2019

Method for making and using cold atmospheric plasma stimulated media for cancer treatment

Inventors: Michael Keidar (Baltimore, MD); Jerome Canady (Lakeland, FL); Dayun Yan (Washington, DC)
Assignee: US Patent Innovations, LLC
C12N5/0693C12N5/0018C12N2500/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,479,979
App. No.
15/392,620
Granted
Nov 19, 2019
Kind
B2
Abstract

A method for preparing cold atmospheric plasma stimulated cell culture media with a cold atmospheric plasma system having a delivery port out of which an inert gas flows. The inert gas may be helium. The method comprises the steps of placing a cell culture media in a first well, the first well having a bottom and having a diameter greater than 20 mm; wherein the cell culture media placed in the first well has a volume of 4 ml or less, treating the cell culture media in the first well with cold atmospheric plasma, wherein the treating is performed with a gap between the delivery port and the bottom of the first well is between 2.5 cm and 3.5 cm, and transferring a portion of the treated media to cultured cancer cells in a second well. The cold atmospheric plasma may be applied for 0.5 minutes to 2 minutes.

Claims (11)

1. A method for preparing stable cold atmospheric plasma stimulated cell culture media with a cold atmospheric plasma system having a delivery port out of which inert gas flows, the method comprising the steps of:

placing a cell culture media in a first well, said first well having a bottom and having a diameter greater than 20 mm; wherein said cell culture media placed in said first well has a volume of 4 ml or less, said cell culture media comprising an amino acid solution not having cysteine or tryptophan;

treating said cell culture media in said first well with cold atmospheric plasma, wherein said treating is performed with a gap between said delivery port and said bottom of said first well is between 2.5 cm and 3.5 cm; and

applying a portion of said treated media to cancer cells.

2. The method according to claim 1 wherein said gap is 3 cm.

3. The method according to claim 1 wherein said step of treating said cell culture media comprises applying cold atmospheric plasma to said cell culture media for 0.5 minutes to 2 minutes.

4. The method according to claim 1 wherein said step of treating said cell culture media comprises applying cold atmospheric plasma to said cell culture media for 1.5 minutes or longer.

5. The method according to claim 1 wherein said cell culture media further comprises Dulbecco's modified Eagle's medium (DMEM).

6. The method according to claim 1 wherein said media further comprises Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS) and 1% (v/v) antibiotic (penicillin and streptomycin) solution.

7. The method according to claim 1 wherein said cell culture media placed in said first well has a volume of 2 ml or less.

8. The method according to claim 1 wherein the inert gas comprises helium from which the cold atmospheric plasma is formed is helium.

Assignments (2)
SECURITY INTEREST Recorded Sep 18, 2019
From: US PATENT INNOVATIONS, LLC
To: ALPINE REVOCABLE TRUST, AS NOTES AGENT
Reel/Frame 050424/0958 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2019
From: KEIDAR, MICHAEL; CANADY, JEROME, DR.; YAN, DAYUN
To: US PATENT INNOVATIONS, LLC
Reel/Frame 048754/0001 →
Continuity (2)
Provisional Application 62271379 · Dec 28, 2015
Related Publication 20170183631A1 · Jun 29, 2017